Annual FCF
-$10.75 M
+$1.50 M+12.21%
December 1, 2023
Summary
- As of February 7, 2025, PHIO annual free cash flow is -$10.75 million, with the most recent change of +$1.50 million (+12.21%) on December 1, 2023.
- During the last 3 years, PHIO annual FCF has fallen by -$1.93 million (-21.91%).
- PHIO annual FCF is now -111.82% below its all-time high of -$5.08 million, reached on December 31, 2012.
Performance
PHIO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$1.95 M
-$176.00 K-9.90%
September 1, 2024
Summary
- As of February 7, 2025, PHIO quarterly free cash flow is -$1.95 million, with the most recent change of -$176.00 thousand (-9.90%) on September 1, 2024.
- Over the past year, PHIO quarterly FCF has increased by +$947.00 thousand (+32.66%).
- PHIO quarterly FCF is now -73.14% below its all-time high of -$1.13 million, reached on March 31, 2013.
Performance
PHIO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$8.11 M
+$947.00 K+10.45%
September 1, 2024
Summary
- As of February 7, 2025, PHIO TTM free cash flow is -$8.11 million, with the most recent change of +$947.00 thousand (+10.45%) on September 1, 2024.
- Over the past year, PHIO TTM FCF has increased by +$2.98 million (+26.86%).
- PHIO TTM FCF is now -164.46% below its all-time high of -$3.07 million, reached on March 31, 2011.
Performance
PHIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
PHIO Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +12.2% | +32.7% | +26.9% |
| 3 y3 years | -21.9% | +32.7% | +26.9% |
| 5 y5 years | -42.9% | +32.7% | +26.9% |
PHIO Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +12.2% | -9.9% | +45.3% | at high | +33.8% |
| 5 y | 5-year | -23.4% | +12.2% | -9.9% | +45.3% | at high | +33.8% |
| alltime | all time | -111.8% | +12.2% | -73.1% | +45.3% | -164.5% | +33.8% |
Phio Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.95 M(+9.9%) | -$8.11 M(-10.5%) |
| Jun 2024 | - | -$1.78 M(-11.6%) | -$9.06 M(-9.9%) |
| Mar 2024 | - | -$2.01 M(-15.1%) | -$10.06 M(-6.5%) |
| Dec 2023 | -$10.75 M(-12.2%) | -$2.37 M(-18.3%) | -$10.75 M(-3.0%) |
| Sep 2023 | - | -$2.90 M(+4.5%) | -$11.09 M(-5.4%) |
| Jun 2023 | - | -$2.78 M(+2.5%) | -$11.72 M(+3.0%) |
| Mar 2023 | - | -$2.71 M(+0.1%) | -$11.38 M(-7.1%) |
| Dec 2022 | -$12.25 M(+2.9%) | -$2.71 M(-23.4%) | -$12.25 M(+1.9%) |
| Sep 2022 | - | -$3.53 M(+44.9%) | -$12.02 M(+5.6%) |
| Jun 2022 | - | -$2.44 M(-31.7%) | -$11.38 M(-6.8%) |
| Mar 2022 | - | -$3.57 M(+44.6%) | -$12.21 M(+2.5%) |
| Dec 2021 | -$11.91 M(+35.0%) | -$2.47 M(-14.7%) | -$11.91 M(-1.3%) |
| Sep 2021 | - | -$2.90 M(-11.4%) | -$12.06 M(+8.2%) |
| Jun 2021 | - | -$3.27 M(-0.1%) | -$11.14 M(+12.5%) |
| Mar 2021 | - | -$3.27 M(+24.7%) | -$9.91 M(+12.3%) |
| Dec 2020 | -$8.82 M(+1.2%) | -$2.62 M(+32.6%) | -$8.82 M(+0.9%) |
| Sep 2020 | - | -$1.98 M(-2.6%) | -$8.74 M(-0.8%) |
| Jun 2020 | - | -$2.03 M(-7.0%) | -$8.81 M(+1.0%) |
| Mar 2020 | - | -$2.19 M(-14.0%) | -$8.73 M(+0.1%) |
| Dec 2019 | -$8.72 M(+15.8%) | -$2.54 M(+23.8%) | -$8.72 M(+10.0%) |
| Sep 2019 | - | -$2.05 M(+5.3%) | -$7.92 M(+0.6%) |
| Jun 2019 | - | -$1.95 M(-10.5%) | -$7.88 M(+1.1%) |
| Mar 2019 | - | -$2.18 M(+24.6%) | -$7.79 M(+3.6%) |
| Dec 2018 | -$7.53 M(-22.6%) | -$1.75 M(-13.0%) | -$7.52 M(-5.7%) |
| Sep 2018 | - | -$2.01 M(+7.9%) | -$7.97 M(-2.5%) |
| Jun 2018 | - | -$1.86 M(-2.5%) | -$8.18 M(-7.3%) |
| Mar 2018 | - | -$1.91 M(-13.4%) | -$8.82 M(-9.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$9.72 M(+25.2%) | -$2.20 M(-0.5%) | -$9.72 M(+9.3%) |
| Sep 2017 | - | -$2.21 M(-11.6%) | -$8.89 M(+7.3%) |
| Jun 2017 | - | -$2.50 M(-10.6%) | -$8.28 M(+8.4%) |
| Mar 2017 | - | -$2.80 M(+103.9%) | -$7.64 M(-1.6%) |
| Dec 2016 | -$7.76 M(+5.3%) | -$1.37 M(-14.4%) | -$7.76 M(-2.8%) |
| Sep 2016 | - | -$1.60 M(-13.7%) | -$7.99 M(-4.3%) |
| Jun 2016 | - | -$1.86 M(-36.4%) | -$8.35 M(+0.3%) |
| Mar 2016 | - | -$2.92 M(+82.8%) | -$8.32 M(+12.8%) |
| Dec 2015 | -$7.37 M(-6.1%) | -$1.60 M(-18.5%) | -$7.37 M(-0.1%) |
| Sep 2015 | - | -$1.96 M(+7.2%) | -$7.38 M(+2.5%) |
| Jun 2015 | - | -$1.83 M(-7.5%) | -$7.20 M(-3.4%) |
| Mar 2015 | - | -$1.98 M(+23.4%) | -$7.45 M(-5.1%) |
| Dec 2014 | -$7.85 M(+22.9%) | -$1.60 M(-9.9%) | -$7.85 M(+1.7%) |
| Sep 2014 | - | -$1.78 M(-14.7%) | -$7.72 M(+0.6%) |
| Jun 2014 | - | -$2.09 M(-12.3%) | -$7.67 M(+0.4%) |
| Mar 2014 | - | -$2.38 M(+61.9%) | -$7.64 M(+19.6%) |
| Dec 2013 | -$6.39 M(+25.8%) | -$1.47 M(-15.2%) | -$6.39 M(+5.2%) |
| Sep 2013 | - | -$1.73 M(-15.8%) | -$6.08 M(+8.4%) |
| Jun 2013 | - | -$2.06 M(+82.4%) | -$5.60 M(+12.1%) |
| Mar 2013 | - | -$1.13 M(-2.4%) | -$5.00 M(-1.6%) |
| Dec 2012 | -$5.08 M(-49.5%) | -$1.16 M(-8.3%) | -$5.08 M(-24.6%) |
| Sep 2012 | - | -$1.26 M(-13.2%) | -$6.74 M(-11.3%) |
| Jun 2012 | - | -$1.45 M(+20.1%) | -$7.59 M(-7.3%) |
| Mar 2012 | - | -$1.21 M(-57.1%) | -$8.19 M(-18.5%) |
| Dec 2011 | -$10.05 M | -$2.82 M(+33.0%) | -$10.05 M(+38.9%) |
| Sep 2011 | - | -$2.12 M(+3.4%) | -$7.23 M(+41.4%) |
| Jun 2011 | - | -$2.05 M(-33.2%) | -$5.12 M(+66.8%) |
| Mar 2011 | - | -$3.07 M | -$3.07 M |
FAQ
- What is Phio Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals annual FCF year-on-year change?
- What is Phio Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals quarterly FCF year-on-year change?
- What is Phio Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Phio Pharmaceuticals?
- What is Phio Pharmaceuticals TTM FCF year-on-year change?
What is Phio Pharmaceuticals annual free cash flow?
The current annual FCF of PHIO is -$10.75 M
What is the all time high annual FCF for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high annual free cash flow is -$5.08 M
What is Phio Pharmaceuticals annual FCF year-on-year change?
Over the past year, PHIO annual free cash flow has changed by +$1.50 M (+12.21%)
What is Phio Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of PHIO is -$1.95 M
What is the all time high quarterly FCF for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high quarterly free cash flow is -$1.13 M
What is Phio Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, PHIO quarterly free cash flow has changed by +$947.00 K (+32.66%)
What is Phio Pharmaceuticals TTM free cash flow?
The current TTM FCF of PHIO is -$8.11 M
What is the all time high TTM FCF for Phio Pharmaceuticals?
Phio Pharmaceuticals all-time high TTM free cash flow is -$3.07 M
What is Phio Pharmaceuticals TTM FCF year-on-year change?
Over the past year, PHIO TTM free cash flow has changed by +$2.98 M (+26.86%)